The hormone, which may in the future will treat 1 diabetes and type 2 diabetes, was discovered by experts from the Harvard Stem Cell Institute (HSCI).
A series of experiments has allowed scientists to determine that the hormone betatrofin increases 30-fold in mice the production of insulin-secreting pancreatic beta cells. These cells, as experts note, the insulin produced only when the body needs it, which makes it possible to provide natural regulation of insulin, thus drastically reducing the number of complications associated with diabetes.
Widespread use of a new method of treating diabetes will not soon - need at least a few years, so it can be used to treat people with diabetes. Opening of scientists, however, have attracted the attention of manufacturers of certain medications.
Very often mellitus type 2 diabetes is associated with obesity in combination with the absence or lack of physical activity. The disease contributes to the gradual decrease in the body of patients in beta-cells, after which the body is therefore not capable of producing the required amount of insulin. The introduction of betatrofina initiates the growth of beta cells, the insulin-producing independently in accordance with the need of the body. This, say the researchers, is to stop the progression of diabetes in humans, or even save them completely from illness.
Scientists have now successfully conducting trials on genetically-modified laboratory mice with diabetes, but betatrofin is present in the human body. Scientists suggest that the market for a new drug will be in 3-5 years. This is the minimum period for this type of medication, usually for various tests required much more time.
An important discovery has helped scientists to make long-known fact that women of beta cells during pregnancy is becoming more increases insulin levels. By studying this relationship in experimental mice, the scientists noticed that this hormone betatrofin as it "turns on" the production of additional beta cells.